American Heart Journal Multicenter Automatic Defibrillator Implantation Trial–Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol Valentina Kutyifa, MD, PhD, Christopher Beck, PhD, Mary W. Brown, MS, David Cannom, MD, James Daubert, MD, Mark Estes, MD, Henry Greenberg, MD, Ilan Goldenberg, MD, Stephen Hammes, MD, PhD, David Huang, MD, Helmut Klein, MD, Reinoud Knops, MD, PhD, Mikhail Kosiborod, MD, PhD, Jeanne Poole, MD, Claudio Schuger, MD, Jagmeet P. Singh, MD, PhD, Scott Solomon, MD, David Wilber, MD, Wojciech Zareba, MD, PhD, Arthur J. Moss, MD American Heart Journal Volume 189, Pages 158-166 (July 2017) DOI: 10.1016/j.ahj.2017.04.014 Copyright © 2017 The Author(s) Terms and Conditions
Figure 1 AAA: S-ICD more effective; BBB: Med Rx more effective; CCC: no difference. American Heart Journal 2017 189, 158-166DOI: (10.1016/j.ahj.2017.04.014) Copyright © 2017 The Author(s) Terms and Conditions
Figure 2 Screening, implantation, and follow-up schedule in MADIT S-ICD. American Heart Journal 2017 189, 158-166DOI: (10.1016/j.ahj.2017.04.014) Copyright © 2017 The Author(s) Terms and Conditions
Figure 3 Organizational structure in MADIT S-ICD. American Heart Journal 2017 189, 158-166DOI: (10.1016/j.ahj.2017.04.014) Copyright © 2017 The Author(s) Terms and Conditions